Comparison of competitive-nested PCR and real-time PCR in detecting BCR-ABL fusion transcripts in chronic myeloid leukemia patients

This publication has 20 references indexed in Scilit:

• Detection and quantification of residual disease in chronic myelogenous leukemia
  Leukemia, 2000
• Monitoring chronic myeloid leukaemia therapy by real‐time quantitative PCR in blood is a reliable alternative to bone marrow cytogenetics
  British Journal of Haematology, 1999
• Accurate and rapid analysis of residual disease in patients with CML using specific fluorescent hybridization probes for real time quantitative RT-PCR
  Leukemia, 1999
• Minimal residual disease after allogeneic bone marrow transplantation for chronic myeloid leukaemia in first chronic phase: correlations with acute graft‐versus‐host disease and relapse
  British Journal of Haematology, 1993
• Minimal Residual Disease after Bone Marrow Transplant for Chronic Myeloid Leukaemia Detected by the Polymerase Chain Reaction
  Leukemia & Lymphoma, 1993
• Detection of bcr - abl Fusion in Chronic Myelogeneous Leukemia by in Situ Hybridization
  Science, 1990
• Fused transcript of abl and bcr genes in chronic myelogenous leukaemia
  Nature, 1985
• Activation of the c-abl oncogene by viral transduction or chromosomal translocation generates altered c-abl proteins with similar in vitro kinase properties.
  Molecular and Cellular Biology, 1985
• The human cellular abl gene product in the chronic myelogenous leukemia cell line K562 has an associated tyrosine protein kinase activity
  Virology, 1985
• A New Consistent Chromosomal Abnormality in Chronic Myelogenous Leukaemia identified by Quinacrine Fluorescence and Giemsa Staining
  Nature, 1973